These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 19363468

  • 1. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
    Kaliberova LN, Krendelchtchikova V, Harmon DK, Stockard CR, Petersen AS, Markert JM, Gillespie GY, Grizzle WE, Buchsbaum DJ, Kaliberov SA.
    Cancer Gene Ther; 2009 Oct; 16(10):794-805. PubMed ID: 19363468
    [Abstract] [Full Text] [Related]

  • 2. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.
    Holzmüller R, Mantwill K, Haczek C, Rognoni E, Anton M, Kasajima A, Weichert W, Treue D, Lage H, Schuster T, Schlegel J, Gänsbacher B, Holm PS.
    Int J Cancer; 2011 Sep 01; 129(5):1265-76. PubMed ID: 21710499
    [Abstract] [Full Text] [Related]

  • 3. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
    Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y, Lesniak MS.
    Br J Cancer; 2009 Apr 07; 100(7):1154-64. PubMed ID: 19277041
    [Abstract] [Full Text] [Related]

  • 4. A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis.
    Jiang G, Jiang AJ, Cheng Q, Tian H, Li LT, Zheng JN.
    Tumour Biol; 2013 Apr 07; 34(2):1263-71. PubMed ID: 23430584
    [Abstract] [Full Text] [Related]

  • 5. The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.
    Tobias AL, Thaci B, Auffinger B, Rincón E, Balyasnikova IV, Kim CK, Han Y, Zhang L, Aboody KS, Ahmed AU, Lesniak MS.
    Stem Cells Transl Med; 2013 Sep 07; 2(9):655-66. PubMed ID: 23926209
    [Abstract] [Full Text] [Related]

  • 6. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
    Kim SM, Woo JS, Jeong CH, Ryu CH, Jang JD, Jeun SS.
    Stem Cells Transl Med; 2014 Feb 07; 3(2):172-82. PubMed ID: 24436439
    [Abstract] [Full Text] [Related]

  • 7. Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo.
    Alonso MM, Gomez-Manzano C, Jiang H, Bekele NB, Piao Y, Yung WK, Alemany R, Fueyo J.
    Cancer Gene Ther; 2007 Aug 07; 14(8):756-61. PubMed ID: 17557108
    [Abstract] [Full Text] [Related]

  • 8. Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.
    Jaime-Ramirez AC, Dmitrieva N, Yoo JY, Banasavadi-Siddegowda Y, Zhang J, Relation T, Bolyard C, Wojton J, Kaur B.
    J Gene Med; 2017 Mar 07; 19(3):. PubMed ID: 28087981
    [Abstract] [Full Text] [Related]

  • 9. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
    Jiang G, Sun C, Li RH, Wei ZP, Zheng JN, Liu YQ.
    J Cancer Res Clin Oncol; 2015 Jan 07; 141(1):75-85. PubMed ID: 25103017
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
    Yamini B, Yu X, Gillespie GY, Kufe DW, Weichselbaum RR.
    Cancer Res; 2004 Sep 15; 64(18):6381-4. PubMed ID: 15374943
    [Abstract] [Full Text] [Related]

  • 11. Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy.
    Zhang J, Chen H, Chen C, Liu H, He Y, Zhao J, Yang P, Mao Q, Xia H.
    Cancer Lett; 2021 Jul 01; 509():26-38. PubMed ID: 33819529
    [Abstract] [Full Text] [Related]

  • 12. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J, Zhou G, Tang D, Chen Y, Cui B, Dai X, Zhang J, Lan Q, Huang Q.
    J Cancer Res Clin Oncol; 2012 Dec 01; 138(12):2079-84. PubMed ID: 22825126
    [Abstract] [Full Text] [Related]

  • 13. Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.
    Aghi M, Rabkin S, Martuza RL.
    Clin Neurosurg; 2006 Dec 01; 53():65-76. PubMed ID: 17380741
    [No Abstract] [Full Text] [Related]

  • 14. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
    Fiveash JB, Gillespie GY, Oliver PG, Zhou T, Belenky ML, Buchsbaum DJ.
    Int J Radiat Oncol Biol Phys; 2008 Jun 01; 71(2):507-16. PubMed ID: 18474311
    [Abstract] [Full Text] [Related]

  • 16. An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.
    Kostova Y, Mantwill K, Holm PS, Anton M.
    Cancer Gene Ther; 2015 Jan 01; 22(1):30-43. PubMed ID: 25501992
    [Abstract] [Full Text] [Related]

  • 17. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.
    Gomez-Gutierrez JG, Nitz J, Sharma R, Wechman SL, Riedinger E, Martinez-Jaramillo E, Sam Zhou H, McMasters KM.
    Virology; 2016 Jan 01; 487():249-59. PubMed ID: 26561948
    [Abstract] [Full Text] [Related]

  • 18. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 19. The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus.
    Fujii K, Kurozumi K, Ichikawa T, Onishi M, Shimazu Y, Ishida J, Chiocca EA, Kaur B, Date I.
    Cancer Gene Ther; 2013 Aug 15; 20(8):437-44. PubMed ID: 23827879
    [Abstract] [Full Text] [Related]

  • 20. Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.
    Gong A, Ge N, Yao W, Lu L, Liang H.
    Cancer Chemother Pharmacol; 2014 Sep 15; 74(3):531-8. PubMed ID: 25047724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.